Sequenom Licenses Methylation Marker IP for Prenatal Tests From Chinese University | GenomeWeb
NEW YORK (GenomeWeb News) — Sequenom today said it has exclusively licensed IP to a non-invasive prenatal genetic analysis technology from the Chinese University of Hong Kong.
 
Under the agreement, Sequenom may use the school’s methylation marker and gene expression-analysis IP for fetal nucleic acids in North America, Europe, Australia, and Japan. It also received non-exclusive rights in China.
 
Sequenom also said the deal includes rights to some methylation and nucleic acid markers.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.